Abstract
Prescribing safe and effective drug therapy is becoming increasingly challenging. Recently, there has been an upward trend in the number of patients experiencing polypragmasy. Thus, according to epidemiological analysis of 180,815 outpatient records in Scotland, 4–9 medications were simultaneously prescribed in 16.9% of cases, 10 or more drugs – in 4.6% of cases. As the number of medications taken by an individual patient increases, so does the likelihood of drug-drug interactions which have clinically important consequences. The number of drug-drug interactions is increasing as new drugs are approved, different metabolic pathways and drug transporters are discovered, and co-prescribing recommendations emerge. This article provides an overview of principles and mechanisms of drug-drug interactions and describes pharmacokinetic and pharmacodynamic interactions associated with antibiotic therapy.
Russian Medical Academy of Continuing Professional Education, Moscow, Russia
S.S. Yudin State Clinical Hospital, Moscow, Russia
Russian Medical Academy of Continuing Professional Education, Moscow, Russia
S.S. Yudin State Clinical Hospital, Moscow, Russia
Russian Medical Academy of Continuing Professional Education, Moscow, Russia
-
1.
Sychev D.A., Otdelenov V.A., Andreev D.A., Bogova O.T., Bordovsky S.P., Salpagarova Z.K., et al. Polypragmasia in clinical practice: problems and solutions. SPb "Profession"; 2016. 224 p. Russian.
-
2.
Finch R.G., Editor. Antibiotic and chemotherapy: antiinfective agents and their use in therapy. 9th Ed. Edinburgh: Saunders/Elsevier; 2010. 900 p.
-
3.
Pai M.P., Momary K.M., Rodvold K.A. Antibiotic drug interactions. Med Clin North Am. 2006;90(6):12231255.
DOI: 10.1016/j.mcna.2006.06.008
-
4.
Steffel J., Verhamme P., Potpara T.S., Albaladejo P., Antz M., Desteghe L., et al.; ESC Scientific Document Group. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330-1393.
DOI: 10.1093/eurheartj/ehy136
-
5.
Prescription Drug Information, Interactions & Side Effects. Available at: www.drugs.com. Accessed November 2021.
-
6.
Indiana University School of Medicine. Clinical Pharmacology. Drug Interactions. Available at: https://druginteractions.medicine.iu.edu/. Accessed November 2021.
-
7.
Sanford Guide. Antimicrobial Stewardship. Available at: www.sanfordguide.com/stewardship/. Accessed November 2021.
-
8.
State Register of Medicines. Available at: https://grls.rosminzdrav.ru/Default.aspx. Accessed November 2021. Russian.
-
9.
Hu J., Xiao Y.H., Zheng Y., Lai Y.X., Fang X.L., Fang Q. Clinical characteristics and risk factors of tigecyclineassociated hypofibrinogenaemia in critically ill patients. Eur J Clin Pharmacol. 2020;76(7):913-922.
DOI: 10.1007/s00228-020-02860-w
-
10.
Vlase L., Popa A., Neag M., Muntean D., Leucuţa S.E. Pharmacokinetic interaction between zolpidem and ciprofloxacin in healthy volunteers. Eur J Drug Metab Pharmacokinet. 2011;35(3-4):83-87.
DOI: 10.1007/s13318-010-0014-9
-
11.
Mori H., Takahashi K., Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev. 2007;39(4):647-657.
DOI: 10.1080/03602530701690341
-
12.
Gatti M., Raschi E., De Ponti F. Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilancepharmacokinetic/pharmacodynamic analysis. Eur J Clin Pharmacol. 2021;77(2):233-239.
DOI: 10.1007/s00228-020-02990-1
-
13.
Crediblemeds. Available at: www.crediblemeds.org. Accessed November 2021.
-
14.
Guo D, Cai Y, Chai D, Liang B, Bai N, Wang R. The cardiotoxicity of macrolides: a systematic review. Pharmazie. 2010;(9):631-640. PMID: 21038838.
-
15.
Owens R.C. Jr., Ambrose P.G. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis. 2005;41(Suppl. 2):S144157.
DOI: 10.1086/428055
-
16.
Bland C.M., Bookstaver P.B., Lu Z.K., Dunn B.L., Rumley K.F. Musculoskeletal safety outcomes of patients receiving daptomycin with HMG-CoA reductase inhibitors. Antimicrob Agents Chemother. 2014;58(10):5726-5731.
DOI: 10.1128/AAC.02910-14
-
17.
van der Linden P.D., Sturkenboom M.C., Herings R.M., Leufkens H.M., Rowlands S., Stricker B.H. Increased risk of achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med. 2003;163(15):1801-1807.
DOI: 10.1001/archinte.163.15.1801
-
18.
Wise B.L., Peloquin C., Choi H., Lane N.E., Zhang Y. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med. 2012;125(12):1228.e231228.e28.
DOI: 10.1016/j.amjmed.2012.05.027
-
19.
Caputy A.J., Kim Y.I., Sanders D.B. The neuromuscular blocking effects of therapeutic concentrations of various antibiotics on normal rat skeletal muscle: a quantitative comparison. J Pharmacol Exp Ther. 1981;217(2):369-378. PMID: 6112258
-
20.
Sokoll M.D., Gergis S.D. Antibiotics and neuromuscular function. Anesthesiology. 1981;55(2):148-159.
DOI: 10.1097/00000542-198108000-00011
-
21.
Tan A., Holmes H.M., Kuo Y.F., Raji M.A., Goodwin J.S. Coadministration of co-trimoxazole with sulfonylureas: hypoglycemia events and pattern of use. J Gerontol A Biol Sci Med Sci. 2015;70(2):247-254.
DOI: 10.1093/gerona/glu072
-
22.
Grün B., Kiessling M.K., Burhenne J., Riedel K.D., Weiss J., Rauch G., Haefeli W.E., Czock D. Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters. Br J Clin Pharmacol. 2013;76(5):787796.
DOI: 10.1111/bcp.12079